Mark Snyder serves as the Senior Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary at Halozyme Therapeutics Inc., a biopharmaceutical company focused on developing and commercializing novel oncology therapies. In his multifaceted role, Snyder is responsible for overseeing all legal matters, ensuring compliance with regulatory requirements, and providing strategic guidance to the company's leadership team. His expertise in corporate governance and compliance has been instrumental in navigating the complex landscape of the biopharmaceutical industry. Prior to joining Halozyme Therapeutics, Snyder held various leadership positions in the legal departments of several prominent healthcare and biotechnology companies. He has a proven track record of successfully managing complex legal issues, including intellectual property, mergers and acquisitions, and corporate governance. Snyder's strategic approach to legal matters has helped Halozyme navigate challenges and seize opportunities in the competitive oncology market. His ability to provide sound legal advice while maintaining a strong focus on compliance has been a key factor in the company's growth and success. Throughout his career, Snyder has demonstrated a commitment to excellence and a deep understanding of the biopharmaceutical industry. His leadership and strategic vision have been critical in shaping Halozyme's legal and compliance strategies. As the company continues to develop and commercialize innovative cancer treatments, Snyder's role in ensuring legal and regulatory compliance will remain vital to Halozyme's mission of improving patient outcomes and advancing the field of oncology.